Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study.
Atheroscler Plus
; 45: 32-38, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-36643997
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Evaluation_studies
/
Observational_studies
Language:
En
Journal:
Atheroscler Plus
Year:
2021
Document type:
Article
Affiliation country:
España
Country of publication:
Países Bajos